[Form 3] Tenon Medical, Inc. Initial Statement of Beneficial Ownership
Nathaniel A. Grawey, Chief Commercial Officer of Tenon Medical (TNON), reported beneficial ownership on a Form 3. He directly holds 138,114 shares of common stock, which are stated to be subject to a vesting schedule and non-transferable, and has an indirect interest in 175,383 shares through SiVantage, Inc. SiVantage owns 710,300 shares and Grawey holds 24.69% of that company.
Nathaniel A. Grawey, Chief Commercial Officer di Tenon Medical (TNON), ha dichiarato la titolarità beneficiaria in un Form 3. Detiene direttamente 138,114 azioni ordinarie, indicate come soggette a un piano di maturazione e non trasferibili, e possiede un interesse indiretto in 175,383 azioni tramite SiVantage, Inc. SiVantage detiene 710,300 azioni e Grawey detiene il 24.69% di quella società.
Nathaniel A. Grawey, Chief Commercial Officer de Tenon Medical (TNON), informó la titularidad beneficiaria en un Form 3. Tiene en propiedad directa 138,114 acciones ordinarias, que se indican como sujetas a un calendario de adquisición (vesting) y no transferibles, y tiene un interés indirecto en 175,383 acciones a través de SiVantage, Inc. SiVantage posee 710,300 acciones y Grawey posee el 24.69% de esa compañía.
Nathaniel A. Grawey, Tenon Medical(TNON)의 최고영업책임자는 Form 3에 실소유권을 신고했습니다. 그는 직접적으로 138,114주의 보통주를 보유하고 있으며 해당 주식들은 베스팅 일정에 따라 부여되며 양도 불가로 명시되어 있고, SiVantage, Inc.를 통해 175,383주의 간접적 이익을 보유하고 있습니다. SiVantage는 710,300주를 보유하고 있으며 Grawey는 그 회사의 24.69%를 보유하고 있습니다.
Nathaniel A. Grawey, Chief Commercial Officer de Tenon Medical (TNON), a déclaré une propriété bénéficiaire sur un Form 3. Il détient directement 138,114 actions ordinaires, précisées comme soumises à un calendrier d'acquisition (vesting) et non transférables, et détient un intérêt indirect dans 175,383 actions via SiVantage, Inc. SiVantage détient 710,300 actions et Grawey détient 24.69% de cette société.
Nathaniel A. Grawey, Chief Commercial Officer von Tenon Medical (TNON), meldete wirtschaftliches Eigentum in einer Form 3. Er hält unmittelbar 138,114 Stammaktien, die als einem Vesting-Zeitplan unterliegend und nicht übertragbar angegeben sind, und hat ein indirektes Interesse an 175,383 Aktien über SiVantage, Inc. SiVantage besitzt 710,300 Aktien und Grawey hält 24.69% dieses Unternehmens.
- None.
- None.
Insights
TL;DR: Routine disclosure of insider holdings showing direct and indirect ownership with a vesting condition on direct shares.
The Form 3 documents Nathaniel Grawey's position as Chief Commercial Officer and quantifies his economic exposure to Tenon Medical: 138,114 directly held common shares (subject to vesting and non-transferability) plus an indirect interest of 175,383 shares via SiVantage, where he owns 24.69%. This is a standard, non-eventful governance disclosure that enhances transparency about insider alignment.
TL;DR: Insider disclosed a total beneficial interest of 313,497 common shares, split between direct and indirect holdings.
The filing shows explicit share counts and the structure of indirect ownership: SiVantage holds 710,300 shares and Grawey's stake in SiVantage translates to 175,383 TNON shares. The direct holdings (138,114) being subject to vesting and non-transferable may affect near-term liquidity of those shares. The disclosure is informational and does not indicate a material corporate development.
Nathaniel A. Grawey, Chief Commercial Officer di Tenon Medical (TNON), ha dichiarato la titolarità beneficiaria in un Form 3. Detiene direttamente 138,114 azioni ordinarie, indicate come soggette a un piano di maturazione e non trasferibili, e possiede un interesse indiretto in 175,383 azioni tramite SiVantage, Inc. SiVantage detiene 710,300 azioni e Grawey detiene il 24.69% di quella società.
Nathaniel A. Grawey, Chief Commercial Officer de Tenon Medical (TNON), informó la titularidad beneficiaria en un Form 3. Tiene en propiedad directa 138,114 acciones ordinarias, que se indican como sujetas a un calendario de adquisición (vesting) y no transferibles, y tiene un interés indirecto en 175,383 acciones a través de SiVantage, Inc. SiVantage posee 710,300 acciones y Grawey posee el 24.69% de esa compañía.
Nathaniel A. Grawey, Tenon Medical(TNON)의 최고영업책임자는 Form 3에 실소유권을 신고했습니다. 그는 직접적으로 138,114주의 보통주를 보유하고 있으며 해당 주식들은 베스팅 일정에 따라 부여되며 양도 불가로 명시되어 있고, SiVantage, Inc.를 통해 175,383주의 간접적 이익을 보유하고 있습니다. SiVantage는 710,300주를 보유하고 있으며 Grawey는 그 회사의 24.69%를 보유하고 있습니다.
Nathaniel A. Grawey, Chief Commercial Officer de Tenon Medical (TNON), a déclaré une propriété bénéficiaire sur un Form 3. Il détient directement 138,114 actions ordinaires, précisées comme soumises à un calendrier d'acquisition (vesting) et non transférables, et détient un intérêt indirect dans 175,383 actions via SiVantage, Inc. SiVantage détient 710,300 actions et Grawey détient 24.69% de cette société.
Nathaniel A. Grawey, Chief Commercial Officer von Tenon Medical (TNON), meldete wirtschaftliches Eigentum in einer Form 3. Er hält unmittelbar 138,114 Stammaktien, die als einem Vesting-Zeitplan unterliegend und nicht übertragbar angegeben sind, und hat ein indirektes Interesse an 175,383 Aktien über SiVantage, Inc. SiVantage besitzt 710,300 Aktien und Grawey hält 24.69% dieses Unternehmens.
FAQ
What shares did Nathaniel Grawey report on the Form 3 for Tenon Medical (TNON)?
What is the nature of the direct shares reported by Nathaniel Grawey?
How does SiVantage, Inc. factor into Grawey's indirect ownership?
What total number of TNON shares does Grawey have a beneficial interest in according to the filing?
What role does Nathaniel Grawey have at Tenon Medical as stated on the form?
